Genmab | GEN - Rentabilidad Por Dividendo

Precio De Mercado
1,717.50
Cambio Diario
3.00 0.17%
Mensual
-5.89%
Anual
23.65%
Q1 Expectativa
1,614.31




Dy Cambio Fecha
Amgen 2.95 0.38 2025-12
argenx SE USD 0 0 2025-03
AstraZeneca USD 1.74 0.4 2025-12
Bayer 0.3 0.09 2025-12
Demant 0 0 2024-12
Fresenius Medical Care 3.53 0.31 2025-12
Galapagos 0 0 2025-03
Genmab 0 0 2025-03
GlaxoSmithKline 4.57 1.52 2025-12
GN Store Nord 0.97 0.19 2022-12
GRIFOLS 1.92 0.17 2025-12
Hikma Pharmaceutical USD 4.02 1.1 2025-12
Lonza 0.74 0.04 2025-12
Merck 1.8 0.22 2025-12
Novartis USD 3.31 0.06 2025-09
Regeneron Pharmaceuticals 0.46 0.01 2025-12
Roche Holding 2.96 0.8 2025-12
Sanofi 4.74 0.25 2025-12
UCB 0.83 0.12 2025-06